Pulse dose glucocorticosteroid therapy in COVID-19 pneumonia patients in an intensive care unit
<b>Introduction:</b> Coronavirus pneumonia occurs with severe lung tissue damage and rapid activation of cytokines and chemokines, called "cytokine storm," and simultaneously with a high risk of thrombosis and thromboembolism. There is no specific therapy for new coronavirus in...
Saved in:
Main Authors: | İlkay Ceylan (Author), Gürcan Güler (Author), Korgün Ökmen (Author), Halil Erkan Sayan (Author), Ebru Karakoç (Author) |
---|---|
Format: | Book |
Published: |
National Scientific Medical Center,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of ROX and mROX indices in predicting intubation in COVID 19 patients treated with high flow nasal oxygen in Intensive Care Unit
by: İlkay Ceylan, et al.
Published: (2021) -
The effect of therapeutic plasma exchange and intravenous immunoglobulin therapy on biomarkers and 28-day mortality in patients with COVID-19 in intensive care unit
by: Korgün Ökmen, et al.
Published: (2023) -
Opinions of Physicians Working in Intensive Care on Telemedicine and Tele-intensive Care
by: Ebru Karakoç, et al.
Published: (2022) -
Glucocorticosteroid in Treatment of Severe Pneumonia
by: Felinda Ariani, et al.
Published: (2013) -
The effect of intensive care specialist on mortality in a Teaching Hospital in Turkey
by: İlkay Ceylan, et al.
Published: (2021)